Serial Number
97822178
Owner
PROTAGONIST THERAPEUTICS, INC.Attorney
Melissa A. NowakFirst Use Date
Aug 22, 2006
Filing Date
Mar 3, 2023
PROTAGONIST THERAPEUTICS Trademark
Serial Number: 97822178
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Melissa A. Nowak CHRISTENSEN O'CONNOR JOHNSON KINDNESS
1201 THIRD AVENUE, SUITE 3600
SEATTLE, WA 98101
United States
Trademark Details
Filing Date
March 3, 2023
Registration Date
Not Registered
First Use Anywhere
August 22, 2006
First Use in Commerce
August 22, 2006
Published for Opposition
August 29, 2023
Goods & Services
Providing healthcare information to healthcare professionals and patients relating to disease states and treatment options; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Scientific research, pharmaceutical research, medical research; technical consultation services in the field of research and product development for the treatment of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; scientific consultation services in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; product development services for others in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, oncological and rare diseases
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of metabolic disorders
